The Life Science industry has been subject to a digital revolution. Like other industries, digitalisation is upending all facets of the value chain with data-driven approaches like Gene Therapy, Personalized Medicine, Advanced Cell and Tissue Engineering, Industry 4.0, Artificial Intelligence, Blockchain, Digital Twins, Internet-of-Medical-Things (IoMT) and Software-as-a-Medical-Device (SaMD). This edited volume covers a broad range of topics related to the digital disruption of the industry. The book includes not only technical contributions on data-driven technologies in gene therapy but also analyses the role of Artificial Intelligence (AI) in Life Science management. The authors discuss current regulatory developments and resulting opportunities and challenges. The book includes business-oriented case studies and presents M&A topics, venture capital and other investor perspectives with a focus on digitalisation. Additionally,  the volume illustrates cultural and ethical challenges and management changes due to digitalisation.weiterlesen